HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction
about
Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVCardiovascular Complications of HIV in Endemic Countries.Premature Coronary Artery Disease and ST-Elevation Myocardial Infarction in a 24-Year-Old Man With Perinatally Acquired Human Immunodeficiency Virus: A Case ReportCardiovascular health knowledge and preventive practices in people living with HIV in Kenya.Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study.Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort studyChanges in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV.Inflammation, immune activation, and cardiovascular disease in HIV.Pathophysiology and management of cardiovascular disease in patients with HIVCopenhagen comorbidity in HIV infection (COCOMO) study: a study protocol for a longitudinal, non-interventional assessment of non-AIDS comorbidity in HIV infection in Denmark.Patterns of Cardiovascular Mortality for HIV-Infected Adults in the United States: 1999 to 2013Lay beliefs about hypertension among HIV-infected adults in Kenya.Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?Mechanisms Influencing Circadian Blood Pressure Patterns Among Individuals with HIV.HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer.Macrophage Inflammation and Cardiovascular Disease in HIV: Mechanistic Insights and Future Directions.HIV and ageing: improving quantity and quality of life.Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer.Alcohol and dietary factors associate with gut integrity and inflammation in HIV-infected adults.Differences by HIV serostatus in coronary artery disease severity and likelihood of percutaneous coronary intervention following stress testing.Human immunodeficiency virus-associated heart failure in sub-Saharan Africa: evolution in the epidemiology, pathophysiology, and clinical manifestations in the antiretroviral era.Cardiovascular outcomes among HIV-infected veterans receiving atazanavir.Utility of 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines in HIV-Infected Adults With Carotid Atherosclerosis.Lipoprotein(a) and HIV: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima-Media Thickness in HIV-Infected Young Women in the Women's Interagency HIV Study.Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy.Clinical characteristics of HIV-infected patients with adjudicated heart failure.HIV and Cardiovascular Disease: We Need a Mechanism, and We Need a Plan.Cardiovascular disease risk assessment in HIV: navigating data-sparse zones.A multinational qualitative investigation of the perspectives and drivers of exercise and dietary behaviors in people living with HIV.Prevalence and Correlates of Smoking Among People Living With HIV in South Africa.Effects of antiretroviral treatment and nadir CD4 count in progression to cardiovascular events and related comorbidities in a HIV Brazilian cohort: a multi-stage approach.Ageing with HIV.Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar.Cardiovascular Risk Reduction in Persons Living With HIV: Treatment Development, Feasibility, and Preliminary Results.HIV-Related Myocardial Vulnerability to Infarction and Coronary Artery Disease.Cardiovascular risk in an HIV-infected population in India.Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection.Sleep Apnea and Heart Failure with a Reduced Ejection Fraction Among Persons Living with HIV.The Use of First Line Highly Active Anti-Retroviral Therapy (HAART) is Not Associated with Qtc Prolongation in HIV Patients.
P2860
Q26777866-B7C32E35-3CF5-44DD-9574-FA55EDD3A96CQ28079826-42165C3C-05D2-4D65-BF5D-57EC18CD35B7Q30244655-9D710760-DE79-4A5B-A121-E4ECB878B3B4Q33629178-C31D5F4C-A775-4648-88C8-4E9A7CA1C404Q35806988-11D71977-92B4-4B43-AE88-452E70A8994BQ36009321-BEA0F302-7656-4926-8411-68EEDFA93102Q36098224-2D092148-91A7-4870-97D4-301EF835C5DBQ36436569-6C67BAAF-90F6-4FCD-97BA-101A9F0A557AQ36957752-8A84C1E3-28D0-4731-BE5B-700A56DD1A34Q37038775-76F26E52-1DC1-42BB-BC5B-209F6C07398AQ37442717-0EA54075-B63F-4343-A66F-7A15A3DED9B9Q37641013-8C68369F-70C8-4407-B9E4-EA21A503B4BDQ37741693-EF4DB53C-1F3C-4751-883C-D26AEA01D503Q38596011-34D977D6-8A98-4393-AC10-3B3571BDCEA6Q38597452-B698A823-D48D-4522-9CD7-36728E29CBC6Q38659387-6E2AA4DB-6FB9-4C6C-889D-D3ECBB198A93Q38757198-DB2051E8-6AE7-4B03-8DEF-273024AFEB64Q38883328-F0A1EC3B-F601-40BB-BA8D-1E8583F5B7D2Q39165028-8671ABE2-7D00-4945-851D-65A9F8E21B5FQ39176685-F0FEC021-BD0E-4F2A-91D7-7F22525D6FE3Q39293076-644729E2-D862-4B94-84FA-5B261EEE640EQ40073553-52C9F9A8-C4EC-4008-A1EB-53D4278944CFQ40129344-31CF5EE6-F0F9-450E-9D67-BD6018E3A967Q40136183-E01C5BAE-3A9C-4B47-BB33-AD130BC0B77CQ40276628-2D2D5968-DD6B-431D-9056-35D5726DF260Q40387290-A26A3CD2-09D4-4CDA-AB98-84D91AB1C93CQ41930865-11BEEA00-31AC-409D-AA1B-702D4E670965Q42423832-8BB43E9F-A307-408D-A428-922AABFA0777Q44504250-E787E0D0-13F5-4AB0-AA33-0219370CDA15Q46798223-D436FA14-582D-4FA4-BC09-E70501052AB6Q47602080-EA36613D-F7B5-40A4-95B7-2484E89283BBQ48146909-6C98302E-8DF9-4F39-8DF6-24A25DF1D4ACQ50001938-8E4E9344-26E9-4F62-8118-CB15FC54FE4FQ50053558-44C3DC11-9764-4873-BDBD-1FCEA248FFE2Q50060469-E2DFDAB5-F01B-443C-94AC-A475B68AE54FQ50256507-3B0C06A6-014D-4363-A77A-244BC8D69890Q50318965-65229E48-1C76-42A7-91E3-C44D042B8EC1Q51779710-97251F6A-9125-48E4-9725-2A09CD8E83E2Q52657950-AC579E2F-78C9-4C0C-8014-9418E07CFFA2Q52682349-8EF7CBD3-DDCD-4D7C-9C72-9F9A2A1B5548
P2860
HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
HIV infection, cardiovascular ...... or acute myocardial infarction
@ast
HIV infection, cardiovascular ...... or acute myocardial infarction
@en
type
label
HIV infection, cardiovascular ...... or acute myocardial infarction
@ast
HIV infection, cardiovascular ...... or acute myocardial infarction
@en
prefLabel
HIV infection, cardiovascular ...... or acute myocardial infarction
@ast
HIV infection, cardiovascular ...... or acute myocardial infarction
@en
P2093
P2860
P50
P1476
HIV infection, cardiovascular ...... or acute myocardial infarction
@en
P2093
Alberta L Warner
Anne-Lise Paisible
Charles Alcorn
Chung-Chou H Chang
Cynthia L Gibert
David A Leaf
David Rimland
Heidi M Crane
Hilary A Tindle
Maria C Rodriguez-Barradas
P2860
P304
P356
10.1097/QAI.0000000000000419
P407
P577
2015-02-01T00:00:00Z